We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+12.46%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$17B
AUM Growth
+$1.34B
(+8.6%)
Cap. Flow
-$377M
Cap. Flow
% of AUM
-2.22%
Top 10 Holdings %
Top 10 Hldgs %
15.59%
Holding
389
New
43
Increased
82
Reduced
143
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$204M |
| 2 |
AbbVie
ABBV
|
+$141M |
| 3 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$130M |
| 4 |
Caterpillar
CAT
|
+$125M |
| 5 |
Johnson Controls International
JCI
|
+$90.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VPHM
VIROPHARMA INC
VPHM
|
+$188M |
| 2 |
Merck
MRK
|
+$155M |
| 3 |
Apple
AAPL
|
+$155M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$131M |
| 5 |
Bread Financial
BFH
|
+$96.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.01% |
| 2 | Industrials | 15.63% |
| 3 | Consumer Discretionary | 14.7% |
| 4 | Technology | 8.94% |
| 5 | Communication Services | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Chefs' Warehouse
CHEF
$4.43B
| $13.4M | 0.08% |
459,300
+33,560
| +8% | +$837K |
|
227
Green Dot
GDOT
$764M
| $12.6M | 0.07% |
501,788
-25,240
| -5% | -$588K |
|
|
CMLS
228
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $12.4M | 0.07% |
+201,215
| New | +$10.3M |
|
229
Vitamin Cottage Natural Grocers
NGVC
$750M
| $11.7M | 0.07% |
275,974
+12,220
| +5% | +$470K |
|
230
Copart
CPRT
$26.8B
| $11M | 0.07% |
+2,409,008
| New | +$10.1M |
|
|
LOCK
231
DELISTED
LifeLock, Inc.
LOCK
| $9.79M | 0.06% |
+596,790
| New | +$9.41M |
|
232
WEX
WEX
$6.42B
| $9.54M | 0.06% |
96,285
-1,665
| -2% | -$156K |
|
233
F5
FFIV
$23.4B
| $9.35M | 0.06% |
102,885
-138,400
| -57% | -$11.8M |
|
234
GE Aerospace
GE
$396B
| $8.45M | 0.05% |
62,920
+11,088
| +21% | +$1.4M |
|
|
MGI
235
DELISTED
MoneyGram International, Inc. New
MGI
| $8.27M | 0.05% |
397,782
-18,510
| -4% | -$376K |
|
|
CAVM
236
DELISTED
Cavium, Inc.
CAVM
| $7.44M | 0.04% |
215,520
-524,570
| -71% | -$19.6M |
|
|
STAY
237
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $6.09M | 0.04% |
+231,790
| New | +$5.72M |
|
238
Occidental Petroleum
OXY
$53.5B
| $5.49M | 0.03% |
60,247
-11,105
| -16% | -$1.01M |
|
239
IPG Photonics
IPGP
$3.9B
| $5.45M | 0.03% |
+70,170
| New | +$4.77M |
|
|
PSIX
240
Power Solutions International
PSIX
$759M
| $5.07M | 0.03% |
+67,470
| New | +$4.42M |
|
|
EV
241
DELISTED
Eaton Vance Corp.
EV
| $4.86M | 0.03% |
113,479
| – | – |
|
|
GRMN
242
Garmin
GRMN
$58.3B
| $4.48M | 0.03% |
97,080
| – | – |
|
243
Goldman Sachs
GS
$309B
| $4.39M | 0.03% |
24,775
-250
| -1% | -$41.2K |
|
|
CSOD
244
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $3.88M | 0.02% |
+72,684
| New | +$3.61M |
|
245
Fastenal
FAST
$57.4B
| $2.59M | 0.02% |
217,740
-27,200
| -11% | -$327K |
|
|
NUAN
246
DELISTED
Nuance Communications, Inc.
NUAN
| $2.27M | 0.01% |
172,095
-3,711,587
| -96% | -$51M |
|
247
Pfizer
PFE
$147B
| $2M | 0.01% |
68,947
| – | – |
|
248
Colgate-Palmolive
CL
$74.4B
| $1.99M | 0.01% |
30,560
+21,650
| +243% | +$1.39M |
|
249
CVS Health
CVS
$126B
| $1.94M | 0.01% |
27,100
| – | – |
|
250
Phillips 66
PSX
$81.2B
| $1.71M | 0.01% |
+22,190
| New | +$1.48M |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Westfield Capital Management held 389 positions worth $17B, up 8.6% from $15.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Westfield Capital Management's Q4 2013 filing shows 43 new, 82 increased, 143 reduced and 65 closed positions. Its largest new stake was Teva Pharmaceuticals: 5,174,039 shares worth $207M. The largest sale was VIROPHARMA INC, an estimated $188M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Westfield Capital Management's largest Q4 2013 buy was Teva Pharmaceuticals: 5,174,039 shares worth $207M.
- Westfield Capital Management added most to AbbVie in Q4 2013, an estimated $141M increase.
- Westfield Capital Management's biggest Q4 2013 reduction was VIROPHARMA INC, cutting an estimated $188M.
- Westfield Capital Management fully exited Citrix Systems Inc in Q4 2013, selling an estimated $131M.
- Westfield Capital Management's ten largest holdings make up 16% of its $17B portfolio in Q4 2013.
- Westfield Capital Management opened 43 new positions and closed 65 in Q4 2013.
- Westfield Capital Management's portfolio value rose 8.6% quarter-over-quarter to $17B.
Based on Westfield Capital Management's 13F filing for Q4 2013, filed 7 Feb 2014.